Lopinavir/ritonavir-based second line antiretroviral treatment in children at National Pediatric Hospital, Phnom Penh, Cambodia

被引：0
|
作者：
Sophan Sam
Vibol Ung
Chantheany Huot
Bunnthy Chan
Kdan Yuvatha
Christian Courpotin
Guillaume Adam
Sopheak Ngin
Eric Nerrienet
Y Meng Chhour
机构：
[1] National Pediatric Hospital,HIV/Hepatitis Laboratory
[2] French Red Cross,undefined
[3] Institute Pasteur,undefined
来源：
Retrovirology | / 6卷 / Suppl 1期
关键词：
Virological Failure; Plasma Viral Load; Resistance Analysis; Immunological Failure; Generation ANRS;
D O I：
10.1186/1742-4690-6-S1-O25
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 36 条
  • [11] Clinical outcome of lopinavir/ritonavir as HIV second-line treatment in single tertiary hospital in Malaysia
    Lee, Kok Soon
    Lam, Karin
    Ng, Chyun
    Lee, Chee Hao
    Rajappan, Mahaletchumi
    Zaid, Masliza
    Ong, Edmund Liang Chai
    HIV MEDICINE, 2023, 24 : 60 - 60
  • [12] Insulin resistance and lipid profiles in HIV-infected Thai children receiving lopinavir/ritonavir-based highly active antiretroviral therapy
    Dejkhamron, Prapai
    Unachak, Kevalee
    Aurpibul, Linda
    Sirisanthana, Virat
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2014, 27 (5-6): : 403 - 412
  • [13] Low Rate of Virological Failure and Maintenance of Susceptibility to HIV-1 Protease Inhibitors With First-Line Lopinavir/Ritonavir-Based Antiretroviral Treatment in Clinical Practice
    Prosperi, Mattia C. F.
    Zazzi, Maurizio
    Punzi, Grazia
    Monno, Laura
    Colao, Grazia
    Corsi, Paola
    Di Giambenedetto, Simona
    Meini, Genny
    Ghisetti, Valeria
    Bonora, Stefano
    Pecorari, Monica
    Gismondo, Maria Rita
    Bagnarelli, Patrizia
    Carli, Tiziana
    De Luca, Andrea
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (12) : 1996 - 2003
  • [14] Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire
    Desmonde, Sophie
    Avit, Divine
    Petit, Junie
    Folquet, Madeleine Amorissani
    Eboua, Francois Tanoh
    Bosse, Clarisse Amani
    Dainguy, Evelyne
    Mea, Vearonique
    Timite-Konan, Marguerite
    Ngbeche, Sylvie
    Ciaranello, Andrea
    Leroy, Valeriane
    PLOS ONE, 2016, 11 (12):
  • [15] Lopinavir/Ritonavir-Based Antiretroviral Treatment (ART) Versus Efavirenz-Based ART for the Prevention of Malaria Among HIV-Infected Pregnant Women
    Natureeba, Paul
    Ades, Veronica
    Luwedde, Flavia
    Mwesigwa, Julia
    Plenty, Albert
    Okong, Pius
    Charlebois, Edwin D.
    Clark, Tamara D.
    Nzarubara, Bridget
    Havlir, Diane V.
    Achan, Jane
    Kamya, Moses R.
    Cohan, Deborah
    Dorsey, Grant
    JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (12): : 1938 - 1945
  • [16] Second-line Antiretroviral Treatment in Resource-Limited Settings: Abandon Lopinavir/Ritonavir Monotherapy or Search for New Candidates?
    Hu, Zhiliang
    Li, Zhen
    Yang, Yongfeng
    Wei, Hongxia
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (05) : 852 - U204
  • [17] Economics of Switching to Second-Line Antiretroviral Therapy with Lopinavir/Ritonavir in Africa: Estimates Based on DART Trial Results and Costs for Uganda and Kenya
    Simpson, Kit N.
    Baran, Robert W.
    Kirbach, Stephanie E.
    Dietz, Birgitta
    VALUE IN HEALTH, 2011, 14 (08) : 1048 - 1054
  • [18] Predictors of Virologic and Clinical Response to Nevirapine versus Lopinavir/Ritonavir-based Antiretroviral Therapy in Young Children With and Without Prior Nevirapine Exposure for the Prevention of Mother-to-child HIV Transmission
    Lindsey, Jane C.
    Hughes, Michael D.
    Violari, Avy
    Eshleman, Susan H.
    Abrams, Elaine J.
    Bwakura-Dangarembizi, Mutsa
    Barlow-Mosha, Linda
    Kamthunzi, Portia
    Sambo, Pauline M.
    Cotton, Mark F.
    Moultrie, Harry
    Khadse, Sandhya
    Schimana, Werner
    Bobat, Raziya
    Zimmer, Bonnie
    Petzold, Elizabeth
    Mofenson, Lynne M.
    Jean-Philippe, Patrick
    Palumbo, Paul
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (08) : 846 - 854
  • [19] Brief Report: Ritonavir Concentrations in Hair Predict Virologic Outcomes in HIV-Infected Adolescents With Virologic Failure on Atazanavir-Based or Ritonavir-Based Second-Line Treatment
    Chawana, Tariro D.
    Nhachi, Charles F. B.
    Nathoo, Kusum
    Ngara, Bernard
    Okochi, Hideaki
    Louie, Alexander
    Kuncze, Karen
    Katzenstein, David
    Metcalfe, John
    Gandhi, Monica
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 88 (02) : 181 - 185
  • [20] Assessing the Efficacy of Lopinavir/Ritonavir-Based Preferred and Alternative Second-Line Regimens in HIV-Infected Patients: A Meta-Analysis of Key Evidence to Support WHO Recommendations
    Huang, Yinqiu
    Huang, Xiaojie
    Luo, Yadong
    Zhou, Yihong
    Tao, Xingbao
    Chen, Hui
    Song, Aixin
    Chen, Yaokai
    Wu, Hao
    FRONTIERS IN PHARMACOLOGY, 2018, 9
1234